Navigation Links
Memory Loss Supplement Manufacturer Partners With Nationally-Syndicated Radio Host John Tesh
Date:2/4/2010

Quincy Bioscience, manufacturer of Prevagen® - a natural brain health supplement to help fight memory loss http://www.prevagen.com, announces their partnership with nationally-syndicated radio talk show host John Tesh. The unique jellyfish protein-based product was first introduced in 2007 and has helped thousands with their learning, memory, and concentration. A partnership between Quincy Bioscience and The John Tesh Radio Show represents the growing story of a jellyfish protein helping improve brain function for people across the United States.

Madison, Wisc. (Vocus) -- Quincy Bioscience, manufacturer of Prevagen® - a memory loss http://www.prevagen.com supplement to help fight memory loss, announces their partnership with nationally-syndicated radio talk show host John Tesh. The unique jellyfish protein-based product was first introduced in 2007 and has helped thousands with their learning, memory, and concentration. A partnership between Quincy Bioscience and The John Tesh Radio Show represents the growing story of a jellyfish protein helping improve brain function for people across the United States.

“The John Tesh Radio Show – Intelligence for Your Life is a natural fit for Prevagen®,” says Quincy Bioscience president Mark Underwood. “Mr. Tesh’s program not only entertains his listeners but helps them lead better lives by sharing a wealth of practical information. Prevagen® works well in the format of the program because of the story behind it.”

Prevagen® was launched in 2007 after twelve years of research went into evaluating whether a jellyfish protein could help with brain aging and the troublesome problems like poor recall, difficulty concentrating, and misplacing items that often accompany aging.

Motivated by his own family experiences with neurodegenerative conditions, Mr. Underwood as an undergraduate at the University of Wisconsin-Milwaukee came across research linking stings of a jellyfish with the symptoms of multiple sclerosis. After several years of research isolating the jellyfish protein and proving it could protect brain cells, Prevagen® - Brain Cell Protection was born.

“In quality of life studies, we have shown Prevagen can help people with short-term memory, word recall, and remember driving directions better,” says Underwood. “John Tesh reaches thousands of listeners who face these challenges every day. We’re excited about the opportunity to help them.”

Quincy Bioscience is a Madison, Wisconsin based biotechnology company focused on the discovery, development and marketing of new compounds to fight the aging process. The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. Quincy Bioscience is developing health applications of the jellyfish protein apoaequorin for dietary supplement and pharmaceutical products. For more information visit www.quincybioscience.com.

“The John Tesh Radio Show” in 2003 and has since become one of the most listened-to voices on the air. The show has recently won Radio Ink magazine’s Reader’s Poll for “Favorite Syndicated Radio Personality” and airs on over 300 stations nationwide.

###

Read the full story at http://www.prweb.com/releases/2010/vitamin/prweb3566334.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New Alzheimers findings: High stress and genetic risk factor lead to increased memory decline
2. Removing Ovaries Before Menopause Leads to Memory, Movement Troubles
3. Boston University School of Medicine researcher recipient of Memory Ride Grant
4. New understanding of basic units of memory
5. Obesity Wont Affect Seniors Memory
6. HRT: A Boost for Libido, But Not Memory
7. Memory tasks require more coordinated brain blood flow for people with high blood pressure
8. Computerized training of working memory is a promising therapeutic strategy in ADHD
9. Alzheimers Foundation of America Holds Fifth Annual National Memory Screening Day
10. Survey Reveals Widespread Lack of Communication With Doctors About Memory Concerns
11. Memory Pharmaceuticals to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Memory Loss Supplement Manufacturer Partners With Nationally-Syndicated Radio Host John Tesh
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: